In last trading session, Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) saw 1,098,553 shares changing hands with its beta currently measuring 1.54. Company’s recent per share price level of $0.82 trading at -$0.03 or -3.49% at ring of the bell on the day assigns it a market valuation of $52.44 Million. That closing price of DFFN’s stock is at a discount of -140.24% from its 52-week high price of $1.97 and is indicating a premium of 74.39% from its 52-week low price of $0.21. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 750.74 Million shares which gives us an average trading volume of 2.12 Million if we extend that period to 3-months.
For Diffusion Pharmaceuticals Inc. (DFFN), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 0. Splitting up the data highlights that, out of 1 analysts covering the stock, none rated the stock as a Sell while none recommended an Overweight rating for the stock. None suggested the stock as a Hold whereas 1 see the stock as a Buy. None analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.05 in the current quarter.
Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) trade information
In the face of being in the red today for losing -3.49%, in the last five days DFFN remained trading in the green while hitting it’s week-highest on Friday, Oct 09 when the stock touched $0.94 price level, adding 12.83% to its value on the day. Diffusion Pharmaceuticals Inc.’s shares saw a change of 77.86% in year-to-date performance and have moved -11.67% in past 5-day. Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) showed a performance of -15.93% in past 30-days. Number of shares sold short was 853.65 Million shares which calculate 402.67 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of $3.5 to the stock, which implies a rise of 326.83% to its current value. Analysts have been projecting $3.5 as a low price target for the stock while placing it at a high target of $3.5. It follows that stock’s current price would jump +326.83% in reaching the projected high whereas dropping to the targeted low would mean a loss of 326.83% for stock’s current value.
Diffusion Pharmaceuticals Inc. (DFFN) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 58.9% during past 5 years. In 2020, company’s earnings growth rate is likely to be around 78.9% while estimates for its earnings growth in next 5 years are of 0%